Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FE9FA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,218
Award facts
- Contract value 100% obligated
- $11,218.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,218.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 mL pens on January 8, 2026, with a completion date of January 9, 2026. This contract is a non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company Cencora, Inc. (doing business as AmerisourceBergen) holding the underlying IDC vehicle. The product will be delivered to the Conshohocken, PA location.
This delivery order reflects the Defense Logistics Agency's pharmaceutical procurement strategy to support military healthcare systems globally. Zepbound, a GLP-1 receptor agonist used for weight management, represents the expanding pharmaceutical portfolio DLA procures for military treatment facilities and veteran healthcare programs. The award demonstrates AmerisourceBergen's continued role as a critical pharmaceutical vendor in the federal supply chain, leveraging its comprehensive IDC to fulfill essential medical commodity requirements for Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FE9FA?
SPE2DR26FE9FA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FE9FA worth?
The government has obligated $11,218 on SPE2DR26FE9FA.
Is contract SPE2DR26FE9FA an order under another contract?
Yes. SPE2DR26FE9FA is a delivery order under SPE2DR25D3104, an indefinite delivery contract.
Was contract SPE2DR26FE9FA competed?
The extent of competition for SPE2DR26FE9FA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award